{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:39:04Z","timestamp":1762270744035},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1977,12,1]],"date-time":"1977-12-01T00:00:00Z","timestamp":249782400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1977,12]]},"DOI":"10.1007\/bf01257019","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T18:15:50Z","timestamp":1111601750000},"page":"253-268","source":"Crossref","is-referenced-by-count":56,"title":["Suppression by GABAergic drugs of the locomotor stimulation induced by morphine, amphetamine, and apomorphine: Evidence for both pre- and post-synaptic inhibition of catecholamine systems"],"prefix":"10.1007","volume":"40","author":[{"given":"J.","family":"Cott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Engel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/BF00501114","volume":"283","author":"N.-E. And\u00e9n","year":"1974","unstructured":"And\u00e9n, N.-E.: Inhibition of the turnover of the brain dopamine after treatment with the gammaaminobutyrate: 2-oxyglutarate transaminase inhibitor aminooxyacetic acid. Naunyn-Schmiedeberg's Arch. Pharmacol.283, 419?424 (1974).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00502071","volume":"279","author":"N.-E. And\u00e9n","year":"1973","unstructured":"And\u00e9n, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol.279, 89?92 (1973).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR3","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0773.1977.tb02083.x","volume":"40","author":"N.-E. And\u00e9n","year":"1977","unstructured":"And\u00e9n, N.-E., Wachtel, H.: Biochemical effects of baclofen (?-parachlorophenyl-GABA) on the dopamine and noradrenaline in the rat brain. Acta pharmacol. et toxicol.40, 310?320 (1977).","journal-title":"Acta pharmacol. et toxicol."},{"key":"CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00500606","volume":"279","author":"C. Atack","year":"1973","unstructured":"Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialdehydecondensate assays for the fluorimetric determination of 5-hydroxyindoles in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.279, 267?284 (1973).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.2042-7158.1970.tb10584.x","volume":"22","author":"C. Atack","year":"1970","unstructured":"Atack, C., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid organic solvent mixtures. J. Pharm. Pharmacol.22, 625?627 (1970).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR6","first-page":"235","volume-title":"Chemical Tools in Catecholamine Research, Vol. II","author":"G. Bartholini","year":"1975","unstructured":"Bartholini, G., Stadler, H.: Cholinergic and GABAergic influence on the dopamine release in extrapyramidal centers. In: Chemical Tools in Catecholamine Research, Vol. II (Almgren, O., Carlsson, A., Engel, J., eds.), pp. 235?241. Amsterdam: North-Holland. 1975."},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00498790","volume":"272","author":"P. B\u00e9dard","year":"1972","unstructured":"B\u00e9dard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol.272, 1?15 (1972).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1748-1716.1958.tb01627.x","volume":"44","author":"\u00c5. Bertler","year":"1958","unstructured":"Bertler, \u00c5., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta physiol. scand.44, 273?292 (1958).","journal-title":"Acta physiol. scand."},{"key":"CR9","first-page":"219","volume-title":"Chemical Tools in Catecholamine Research, Vol. II","author":"A. Carlsson","year":"1975","unstructured":"Carlsson, A.: Dopaminergic autoreceptors. In: Chemical Tools in Catecholamine Research, Vol. II (Almgren, O., Carlsson, A., Engel. J., eds.), pp. 219?225. Amsterdam: North-Holland Publ. Co. 1975."},{"key":"CR10","unstructured":"Carlsson, A., Biswas, B.: Effect of GABA, administered intracerebroventricularly or intraperitoneally, on brain monoamines and on locomotor activity. Paper presented at the International Symposium on ?Interactions among putative neurotransmitters in the brain?, Milan, Italy, October 26?28, 1976."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00508904","volume":"275","author":"A. Carlsson","year":"1972","unstructured":"Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brainin vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol.275, 153?168 (1972).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR12","first-page":"167","volume-title":"Catecholamines and Behavior, Vol. 2","author":"D. H. Clouet","year":"1976","unstructured":"Clouet, D. H.: Possible roles of catecholamines in the action of narcotic drugs. In: Catecholamines and Behavior, Vol. 2 (Friedhoff, A. J., ed.), pp. 167?196. New York: Plenum. 1976."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.2042-7158.1976.tb04030.x","volume":"28","author":"A. R. Cools","year":"1976","unstructured":"Cools, A. R., Janssen, H. J.:?-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol. J. Pharm. Pharmacol.28, 70?74 (1976).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR14","volume-title":"International Symposium on Amphetamines and Related Compounds","year":"1970","unstructured":"Costa, E., Garattini, S., eds.: International Symposium on Amphetamines and Related Compounds. New York: Raven Press. 1970."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00505087","volume":"295","author":"J. M. Cott","year":"1976","unstructured":"Cott, J. M., Carlsson, A., Engel, J., Lindqvist, M.: Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Naunyn-Schmiedeberg's Arch. Pharmacol.295, 203?209 (1976).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR16","doi-asserted-by":"crossref","unstructured":"Cott, J., Engel, J.: Antagonism of the analeptic activity of thyrotropinreleasing hormone (TRH) by agents which enhance GABA transmission. Psychopharmacology. In press (1976).","DOI":"10.1007\/BF00439101"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.2042-7158.1976.tb04187.x","volume":"28","author":"A. Dray","year":"1976","unstructured":"Dray, A., Straughan, D. W.: Synaptic mechanisms in the substantia nigra. J. Pharm. Pharmacol.28, 400?405 (1976).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR18","first-page":"2","volume-title":"Current Developments in Psychopharmacology","author":"J. Engel","year":"1976","unstructured":"Engel, J., Carlsson, A.: Catecholamines and behavior. In: Current Developments in Psychopharmacology (Valzelli, L., Essman, W. B., eds.), Vol. 4, pp. 2?32. New York: Spectrum Pub. Inc. 1976."},{"key":"CR19","first-page":"169","volume-title":"GABA in Nervous System Function","author":"S. Fahn","year":"1976","unstructured":"Fahn, S.: Regional distribution studies of GABA and other putative neurotransmitters and their enzymes. In: GABA in Nervous System Function (Roberts, E., Chase, T. N., Tower, D. B., eds.), pp. 169?186. New York: Raven Press. 1976."},{"key":"CR20","first-page":"177","volume":"53","author":"K. Fuxe","year":"1975","unstructured":"Fuxe, K., H\u00f6kfelt, T., Ljungdahl, \u00c5., Agnati, L., Johansson, O., Perez de la Mora, M.: Evidence for an inhibitory gabergic control of the mesolimbic dopamine neurons: possibility of improving treatment of schizophrenia by combined treatment with neuroleptics and gabergic drugs. Medical Biology53, 177?183 (1975).","journal-title":"Medical Biology"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF01248769","volume":"39","author":"A. R. Green","year":"1976","unstructured":"Green, A. R., Tordoff, A. F. C., Bloomfield, M. R.: Elevation of brain GABA concentrations with amino-oxyacetic acid: effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. J. Neural Transmission39, 103?112 (1976).","journal-title":"J. Neural Transmission"},{"key":"CR22","first-page":"479 to 485","volume-title":"GABA in Nervous System Function","author":"O. Hornykiewicz","year":"1976","unstructured":"Hornykiewicz, O., Lloyd, K. G., Davidson, L.: The GABA system, function of the basal ganglia, and Parkinson's disease. In: GABA in Nervous System Function (Roberts, E., Chase, T. N., Tower, O. B., eds.), pp. 479 to 485. New York: Raven Press. 1976."},{"key":"CR23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4613-4574-9_9","volume-title":"New Concepts in Neurotransmitter Regulation","author":"L. L. Iversen","year":"1973","unstructured":"Iversen, L. L., Schon, F. E.: The use of autoradiographic techniques for the identification and mapping of transmitter specific neurones in CNS. In: New Concepts in Neurotransmitter Regulation (Mandel, A., ed.), pp. 153?193. New York: Plenum Press. 1973."},{"key":"CR24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0773.1976.tb03190.x","volume":"39","author":"L K\u00e4\u00e4ri\u00e4inen","year":"1976","unstructured":"K\u00e4\u00e4ri\u00e4inen, L: Effects of aminooxyacetic acid and baclofen on the catalepsy and the increase of mesolimbic and striatal dopamine turnover induced by haloperidol in rats. Acta pharmacol. et toxicol.39, 393?400 (1976).","journal-title":"Acta pharmacol. et toxicol."},{"key":"CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00501936","volume":"274","author":"W. Kehr","year":"1972","unstructured":"Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3, 4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol.274, 273?280 (1972).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR26","first-page":"563","volume":"26","author":"K. Kuschinsky","year":"1976","unstructured":"Kuschinsky, K.: Actions of narcotics on brain dopamine metabolism and their relevance for ?psychomotor? effects. Arzneim.-Forsch. (Drug Res.)26, 563?567 (1976).","journal-title":"Arzneim.-Forsch. (Drug Res.)"},{"key":"CR27","first-page":"153","volume-title":"Advances in Neurology, Vol. 5","author":"P. L. McGeer","year":"1974","unstructured":"McGeer, P. L., Fibiger, H. C., Maler, L., Hattori, T., McGeer, E. G.: Evidence for descending pallido-nigral GABA-containing neurons. In: Advances in Neurology, Vol. 5 (McDowell, F., Barbeau, A., eds.), pp. 153?160. New York: Raven Press. 1974."},{"key":"CR28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF00427279","volume":"49","author":"P.-E. Melberg","year":"1976","unstructured":"Melberg, P.-E., Ahlenius, S., Engel, J., Lundborg, P.: Ontogenic development of locomotor activity and rate of tyrosine hydroxylation. Psychopharmacology49, 119?123 (1976).","journal-title":"Psychopharmacology"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.2042-7158.1976.tb02784.x","volume":"28","author":"D. Peri?i?","year":"1976","unstructured":"Peri?i?, D., Walters, J. R.: Dopamine in substantia nigra and cortex after?-butyrolactone treatment. J. Pharm. Pharmacol.28, 527?530 (1976).","journal-title":"J. Pharm. Pharmacol."},{"key":"CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0006-8993(76)90873-8","volume":"110","author":"C. Pycock","year":"1976","unstructured":"Pycock, C., Horton, R.: Evidence for an accumbens-pallidal pathway in the rat and its possible gabaminergic control. Brain Res.110, 629?634 (1976 a).","journal-title":"Brain Res."},{"key":"CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00427286","volume":"49","author":"C. Pycock","year":"1976","unstructured":"Pycock, C., Horton, R.: Possible GABA-mediated control of dopamine-dependent behavioural effects from the nucleus accumbens of the rat. Psychopharmacology49, 173?178 (1976 b).","journal-title":"Psychopharmacology"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-1-4684-3066-0_22","volume-title":"Neurohumoral Coding of Brain Function","author":"E. Roberts","year":"1974","unstructured":"Roberts, E.: A model of the vertebrate nervous system based largely on disinhibition: a key role of the GABA system. In: Neurohumoral Coding of Brain Function (Myers, R. D., ed.), pp. 419?449, New York: Plenum Press. 1974."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/0006-2952(70)90086-9","volume":"19","author":"R. H. Roth","year":"1970","unstructured":"Roth, R. H., Suhr, Y.: Mechanism of the?-hydroxybutyrate-induced increase in brain dopamine and its relationship to ?sleep?. Biochem. Pharmac.19, 3001?3012 (1970).","journal-title":"Biochem. Pharmac."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/B978-0-08-017922-3.50103-9","volume-title":"Frontiers of Catecholamine Research","author":"R. H. Roth","year":"1973","unstructured":"Roth, R. H., Walters, J. R., Agbajanian, G. K.: Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Frontiers of Catecholamine Research (Usdin, E., Snyder, S., eds.), pp. 567?574. New York: Pergamon. 1973."},{"key":"CR35","first-page":"369","volume-title":"Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes","author":"R. H. Roth","year":"1974","unstructured":"Roth, R. H., Walters, J. R., Morgenroth, V. H., III: Effects of alterations in impulse flow on transmitter metabolism in central dopaminergic neurons. In: Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes (Usdin, E., ed.), pp. 369?384. New York: Raven Press. 1974."},{"key":"CR36","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00501479","volume":"275","author":"G. Stock","year":"1973","unstructured":"Stock, G., Magnusson, T., And\u00e9n, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol.275, 347?361 (1973).","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"CR37","first-page":"733","volume":"50","author":"T. P. Waalkes","year":"1957","unstructured":"Waalkes, T. P., Udenfriend, S.: A fluorometric method for the estimation of tyrosine in plasma and tissues. J. Lab. clin. Med.50, 733?736 (1957).","journal-title":"J. Lab. clin. Med."},{"key":"CR38","unstructured":"Wachtel, H., And\u00e9n, N.-E.: Motor activity following injections of GABA and GABA-like drugs into the nucleus accumbens. (In manuscript.)"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0006-2952(61)90023-5","volume":"5","author":"D. P. Wallach","year":"1961","unstructured":"Wallach, D. P.: Studies on the GABA pathway. 1. The inhibition of?-aminobutyric acid-?-ketogluturic acid transaminase in vitro and in vivo by U-7524 (aminooxyacetic acid). Biochem. Pharmac.5, 323?331 (1961).","journal-title":"Biochem. Pharmac."}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01257019.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01257019\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01257019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T12:26:09Z","timestamp":1586175969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01257019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1977,12]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1977,12]]}},"alternative-id":["BF01257019"],"URL":"https:\/\/doi.org\/10.1007\/bf01257019","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1977,12]]}}}